Gene · 9423
NTN1: netrin 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. NTN1: netrin 1. Genes, record 9423. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/9423
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O95631 | Netrin-1 | 604 | 5 | Ensembl, GeneID, HGNC |
Source UniProt
Patents83
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026510571 A | 2026-04-08 | 1 | O95631 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 147 | O95631 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 120 | O95631 | Espacenet |
| KR 1020250155013 A | 2025-10-29 | 1 | O95631 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 9625 | O95631 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 1834 | O95631 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 3321 | O95631 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 3376 | O95631 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 7190 | O95631 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 7190 | O95631 | Espacenet |
1 to 10 of 83
See all 83 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,868
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | NTN1 papers | Newest fiscal year |
|---|---|---|---|
| R35GM135160 | Coordinated Cytoskeletal Dynamics and Membrane Remodeling in Cellular Shape Change | 9 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 8 | 2025 |
| P01HL131481 | Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases | 7 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 7 | 2025 |
| P20GM103440 | Nevada IDeA Networks of Biomedical Research Excellence (INBRE) | 5 | 2025 |
| R01NS058721 | ACC: Callosal Agenesis as a Window into Common Neurodevelopmental Disorders | 5 | 2025 |
| P30AG066511 | Goizueta Alzheimer's Disease Research Center | 4 | 2025 |
| P30AG072975 | Rush Alzheimer's Disease Research Center | 4 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 4 | 2025 |
| UL1TR002378 | Georgia Clinical & Translational Science Alliance (Georgia CTSA) | 4 | 2025 |
1 to 10 of 1,868Source NIH's project files
See all 1,868 nih grantsPapers2,840
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of comprehensive genetic factors, pathways, and shared genetic architecture of putamen volume in adolescent cohort. | Transl Psychiatry | 2026 | 42816494 | PubTator, text mining | PubMed |
| Sex-dependent effects of neonatal hyperoxia on prefrontal cortex development. | JCI Insight | 2026 | 42809343 | PubTator, text mining | PubMed |
| KIF1A-Mediated Axonal Transport of Netrin-1 in iPSC-Derived Human Forebrain Neurons. | Cytoskeleton (Hoboken) | 2026 | 42799673 | PubTator, text mining | PubMed |
| Netrin-1 and UNC5H receptors: role in cell fate determination and carcinogenesis. | Biochem J | 2026 | 42788717 | PubTator, text mining | PubMed |
| A guide to selecting high-performing antibodies for Netrin-1 (UniProt ID: O95631) for use in western blot and immunoprecipitation. | F1000Res | 2026 | 42760910 | PubTator, text mining | PubMed |
| Peptides whose levels change during the attack period in episodic migraine: NETRIN-1 and amylin. | Front Neurol | 2026 | 42755650 | PubTator, text mining | PubMed |
| Biomarker Insights into Diabetic Foot Ulcers: Evaluating Pentraxin-3 and Netrin-1 for Diagnosis and Clinical Associations. | Int J Low Extrem Wounds | 2026 | 42704080 | PubTator, text mining | PubMed |
| Development of Netrin-1-targeted peptide probes derived from the Netrin-1/DCC complex for noninvasive imaging of tumors. | Bioorg Chem | 2026 | 42702132 | PubTator, text mining | PubMed |
| Indole-3-carboxylic acid promotes senescence of colorectal cancer cells by inhibiting the binding of Netrin-1 to UNC5B. | Cell Signal | 2026 | 42665151 | PubTator, text mining | PubMed |
| Macrophage trafficking and efferocytosis in atherosclerotic plaque regression: Molecular mechanisms and therapeutic perspectives. | Biomed Pharmacother | 2026 | 42648028 | PubTator, text mining | PubMed |
1 to 10 of 2,840
See all 2,840 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/9423
GET https://conductscience.org/api/genes/v1/9423/patents?page=2